facebook twitter google print email
Media Contact:Katherine Unger Baillie | kbaillie@upenn.edu | 215-898-9194March 12, 2012

Penn Researchers Find Epstein Barr-like Virus Infects and May Cause Cancer in Dogs

PHILADELPHIA -- More than 90 percent of humans have antibodies to the Epstein Barr virus.  Best known for causing mononucleosis, or “the kissing disease,” the virus has also been implicated in more serious conditions, including Hodgkin’s, non-Hodgkin’s and Burkitt’s lymphomas.  Yet little is known about exactly how EBV triggers these diseases.

Penn to Study How to Make Military More Resistant to Stress

March 7, 2012

Seema Bhatnagar of the Perelman School of Medicine comments on leading a study about how toenhance stress resilience in military personnel.

Study Suggests Breakthrough in Organ Transplants

March 8, 2012

Abraham Shaked of the Perelman School of Medicine comments on a study about organ transplants.

Article Source: Los Angeles Times

Crystal Light & SEPTA Tokens Boost Cancer Tests

March 7, 2012

Carmen Guerra and Eliot Nierman of the Perelman School of Medicine comment on improving cancer screening.

Article Source: 6abc.com

Penn, Wistar Researchers Thwart HIV Without Antiviral Drugs

March 8, 2012

Penn and Wistar researchers are featured for their work to control HIV without antiviral drugs.

Article Source: Philadelphia Inquirer

Smoking Linked to Higher Rate of Psoriasis: Study

March 2, 2012

Joel Gelfand of the Perelman School of Medicine shares his comments about smoking being linked to psoriasis.

Article Source: HealthDay

Medical Community Disturbed by China’s Organ Centers

March 6, 2012

Arthur Caplan of the Perelman School of Medicine comments on a report of an organ-harvesting facility in China.

Article Source: Epoch Times (Australia)

An Unsung Victory in Healthcare

March 6, 2012

Ezekiel Emanuel of the Perelman School of Medicine and the Wharton School shares his thoughts about electronic health records.

Article Source: Reuters
facebook twitter google print email
Media Contact:Karen Kreeger | Karen.kreeger@uphs.upenn.edu | 215-349-5658March 5, 2012

New Universal Platform for Cancer Immunotherapy Developed by Penn-led Team

Researchers from the Perelman School of Medicine at the University of Pennsylvania report this month in Cancer Research a universal approach to personalized cancer therapy based on T cells. It is the first time a system for making an adaptable, engineered T-cell to attack specific tumor types has been proposed, depending on which abnormal proteins, called antigens, are expressed by individual patients’ tumor cells.

facebook twitter google print email
Media Contact:Kim Menard | Kim.Menard@uphs.upenn.edu | 215-662-6183March 6, 2012

Aggressive Traumatic Brain Injury Care Improves Outcomes, Reduces Long-term Costs, Penn Study Shows

Aggressive treatment for severe traumatic brain injuries costs more than routine care, yet yields significantly better outcomes, improved quality of life, and lower long term care costs, according to a new study by researchers in the Perelman School of Medicine at the University of Pennsylvania. For example, in 20 year old traumatic brain injury survivor, aggressive care leads to significantly improved outcomes and costs nearly $100,000 less compared to routine care.